Latest Heavy metal Stories

Season 12 Premieres Saturday, June 1st at 11:00 PM ET/PT With New Look, New Segments and Same Great Hosts NEW YORK, May 23, 2013 /PRNewswire/ -- It's time to get metaled up. VH1 Classic's centerpiece in original programming, "That Metal Show" is returning for its 12(th) season. The acclaimed hard rock and heavy metal talk show hosted by Eddie Trunk, Don Jamieson, and Jim Florentine kicks off the latest season on Saturday, June 1(st) at 11:00PM ET/PT. "That Metal Show" is back...

CARLSBAD, Calif., May 23, 2013 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS), the leader in antisense therapeutics, today announced that management will present a company overview at the Deutsche Bank 38(th) Annual dbAccess Health Care Conference on Thursday, May 30, 2013 at 8:40 a.m. ET in Boston, MA. A live audio webcast of the presentation will be available on the "Investors & Media" section of the Company's Web site, www.isispharm.com. A replay will be available...

OHK Medical Devices Ltd., manufacturer of the HemaClear® single-use, sterile, exsanguinating tourniquet device, announced today that it will hold its first annual Italian distributor and user conference; May 22, 2013 in Rome, Italy. Haifa, Israel (PRWEB) May 15, 2013 OHK Medical Devices Ltd., manufacturer of the HemaClear® single-use, sterile exsanguinating tourniquet device, announced today that it will hold its first annual Italian distributor and user conference; May 22, 2013...

CARLSBAD, Calif., May 13, 2013 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS), the leader in antisense therapeutics, today announced that management will present a company overview at the 2013 UBS Global Healthcare Conference on Monday, May 20, 2013 at 9:00 a.m. ET in New York, NY. A live audio webcast of the presentation will be available on the "Investors & Media" section of the Company's Web site, www.isispharm.com. A replay will be available on the Isis Web...

CARLSBAD, Calif., May 8, 2013 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today the pricing of an underwritten public offering of 9,000,000 shares of its common stock, offered at a price to the public of $19.00 per share. The gross proceeds to Isis from this offering are expected to be $171.0 million, before deducting the underwriting discount and other estimated offering expenses payable by Isis. The offering is expected to close on or about May 14, 2013,...

Magisto's Mother's Day challenge seeks to turn everyday family videos and photos into a creative tribute to mom and launches new song from Osborne NEW YORK, May 8, 2013 /PRNewswire/ -- Magisto has teamed up with multi-platinum selling recording artist and seven-time Grammy nominee Joan Osborne to celebrate Mother's Day with a new form of music discovery that brings together powerful user-generated video production technology and musical artistry. Joan's new song "Born To See You...

Gene Simmons to Host Pre-Expo Q&A Session NOVI, Mich., May 7, 2013 /PRNewswire/ -- The Eternal Image Group LLC., (the "Company"), a licensing company active in the memorial products industry, today announced that its official KISS(TM) casket and urn models will be at the 2013 Indianapolis KISS Fan Expo. The show runs on May 11 and May 12 at the Indianapolis Marriott East. The Expo is celebrating fifteen years in Indianapolis, as well as marking the fortieth anniversary of the rock...

Brett Smith for redOrbit.com - Your Universe Online Known for her lethal lips, Batman villainess Poison Ivy might appreciate a new study from researchers at the University of California, Berkeley who found dangerous levels of lead, chromium and other metals in a number of commonly sold lipsticks. Previous research, including a 2011 FDA study, has found toxic metals in commercial lipsticks, but the UC Berkeley team has specifically studied how long-term exposure to various...

CARLSBAD, Calif., May 2, 2013 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announces the following webcast: What: Isis Pharmaceuticals' First Quarter 2013 Financial Results and Highlights Conference Call When: Tuesday, May 7, 2013 at 4:30 p.m. ET /1:30 p.m. PT Where: www.isispharm.com How: Live on the Internet. Simply log onto our Web site listed above. If you are unable to participate during...

CARLSBAD, Calif., April 22, 2013 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS), the leader in antisense therapeutics, today announced that management will present a company overview at the 12(th) Annual Needham Healthcare Conference on Tuesday, April 30, 2013 at 11:20 a.m. ET in New York, NY. A live audio webcast of the presentation will be available on the "Investors & Media" section of the Company's Web site, www.isispharm.com. A replay will be available on the...